Oncology Intelligence Digest September 01, 2026 The FDA approved rusfertide (Mimrylo) for erythrocytosis in polycythemia vera on August…
Oncology Intelligence Membership Required
You must be a Oncology Intelligence member to access this content.
Already a member? Log in here